or Try an Advanced Search...

    Technical Analysis for TBPH - Theravance Biopharma, Inc.

    Grade Last Price % Change Price Change
    B 9.97 0.50% 0.05
    TBPH closed up 0.5 percent on Wednesday, November 20, 2024, on 1.87 times normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical TBPH trend table...
    Date Alert Name Type % Chg
    Pocket Pivot Bullish Swing Setup 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Multiple of Ten Bearish Other 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Pocket Pivot Bullish Swing Setup 0.50%
    Upper Bollinger Band Walk Strength 0.50%
    Outside Day Range Expansion 0.50%
    Above Upper BB Strength 0.50%
    Upper Bollinger Band Touch Strength 0.50%
    Upper Bollinger Band Walk Strength 5.06%
    Older End-of-Day Signals for TBPH ...

       Recent Intraday Alerts

    Alert Time
    Possible Pocket Pivot about 17 hours ago
    Up 1% about 21 hours ago
    Rose Above Previous Day's High about 21 hours ago
    60 Minute Opening Range Breakout about 22 hours ago
    2x Volume Pace about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    TBPH Chart by TradingView
    Basic chart:

    Profile

    Theravance Biopharma, Inc. operates as a biopharmaceutical company. It provides discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system (CNS)/pain. The company is based in George Town, Cayman Islands. Theravance Biopharma, Inc. operates as a subsidiary of Theravance Inc.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Pain Medication Respiratory Diseases Bacterial Infections

    Is TBPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Theravance Biopharma to Participate in an Upcoming Investor Conference
    Nov 14 Theravance Biopharma Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Nov 13 Baupost's top Q3 trades include Jazz exit, new Dollar General stake
    Nov 13 Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y
    Nov 13 Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...
    Nov 13 Theravance Biopharma, Inc. (TBPH) Q3 2024 Earnings Call Transcript
    Nov 12 Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates
    Nov 12 Theravance Biopharma, Inc. 2024 Q3 - Results - Earnings Call Presentation
    Nov 12 Theravance Biopharma GAAP EPS of -$0.26 misses by $0.03, revenue of $16.87M beats by $1.45M
    Nov 12 Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value
    See more TBPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.71
    52 Week Low 7.44
    Average Volume 188,274
    200-Day Moving Average 8.81
    50-Day Moving Average 8.52
    20-Day Moving Average 8.93
    10-Day Moving Average 9.38
    Average True Range 0.34
    RSI (14) 72.68
    ADX 37.43
    +DI 41.13
    -DI 10.36
    Chandelier Exit (Long, 3 ATRs) 9.24
    Chandelier Exit (Short, 3 ATRs) 9.16
    Upper Bollinger Bands 10.04
    Lower Bollinger Band 7.82
    Percent B (%b) 0.97
    BandWidth 24.93
    MACD Line 0.37
    MACD Signal Line 0.25
    MACD Histogram 0.1175
    Fundamentals Value
    Market Cap 496.49 Million
    Num Shares 49.8 Million
    EPS -1.03
    Price-to-Earnings (P/E) Ratio -9.68
    Price-to-Sales 7.89
    Price-to-Book 1.74
    PEG Ratio -0.05
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.56
    Resistance 3 (R3) 10.53 10.32 10.46
    Resistance 2 (R2) 10.32 10.17 10.33 10.42
    Resistance 1 (R1) 10.14 10.08 10.23 10.17 10.39
    Pivot Point 9.93 9.93 9.97 9.94 9.93
    Support 1 (S1) 9.75 9.78 9.84 9.78 9.55
    Support 2 (S2) 9.54 9.69 9.55 9.52
    Support 3 (S3) 9.36 9.54 9.48
    Support 4 (S4) 9.39